$3.69 Billion is the total value of Artal Group S.A.'s 152 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS INC | $280,443,000 | -18.1% | 71,178,364 | 0.0% | 7.61% | -0.7% | |
| WW | WW INTL INC | $239,019,000 | -11.6% | 14,818,300 | 0.0% | 6.49% | +7.2% | |
| SEER | SEER INC | $108,348,000 | -33.9% | 4,750,000 | 0.0% | 2.94% | -19.9% | |
| MORF | MORPHIC HLDG INC | $75,100,000 | -16.3% | 1,585,049 | 0.0% | 2.04% | +1.4% | |
| BMY | BRISTOL-MYERS SQUIBB COcall | $62,350,000 | +5.4% | 1,000,000 | 0.0% | 1.69% | +27.8% | |
| ERASCA INC | $49,423,000 | -26.6% | 3,172,221 | 0.0% | 1.34% | -11.0% | ||
| SAGE | SAGE THERAPEUTICS INC | $42,540,000 | -4.0% | 1,000,000 | 0.0% | 1.15% | +16.4% | |
| FHTX | FOGHORN THERAPEUTICS INC | $39,353,000 | +64.2% | 1,720,720 | 0.0% | 1.07% | +99.3% | |
| NTLA | INTELLIA THERAPEUTICS INC | $32,516,000 | -11.9% | 275,000 | 0.0% | 0.88% | +6.9% | |
| TALS | TALARIS THERAPEUTICS INC | $31,563,000 | +12.8% | 2,064,262 | 0.0% | 0.86% | +36.7% | |
| ALVR | ALLOVIR INC | $30,064,000 | -48.4% | 2,323,371 | 0.0% | 0.82% | -37.4% | |
| GOSS | GOSSAMER BIO INC | $26,680,000 | -10.0% | 2,358,968 | 0.0% | 0.72% | +9.2% | |
| OMEGA THERAPEUTICS INC | $25,759,000 | -39.9% | 2,273,530 | 0.0% | 0.70% | -27.1% | ||
| SDGR | SCHRODINGER INC | $24,381,000 | -36.3% | 700,000 | 0.0% | 0.66% | -22.7% | |
| REPL | REPLIMUNE GROUP INC | $24,390,000 | -8.6% | 900,000 | 0.0% | 0.66% | +10.9% | |
| ATRA | ATARA BIOTHERAPEUTICS INC | $23,640,000 | -12.0% | 1,500,000 | 0.0% | 0.64% | +6.7% | |
| PRAX | PRAXIS PRECISION MEDICINES I | $23,640,000 | +6.5% | 1,200,000 | 0.0% | 0.64% | +29.2% | |
| AUPH | AURINIA PHARMACEUTICALS INC | $22,870,000 | +3.3% | 1,000,000 | 0.0% | 0.62% | +25.5% | |
| GBIO | GENERATION BIO CO | $19,924,000 | -71.8% | 2,814,191 | 0.0% | 0.54% | -65.7% | |
| IKNA | IKENA ONCOLOGY INC | $19,431,000 | -0.6% | 1,549,513 | 0.0% | 0.53% | +20.3% | |
| NG | NOVAGOLD RES INC | $17,836,000 | -0.3% | 2,600,000 | 0.0% | 0.48% | +21.0% | |
| APTX | APTINYX INC | $16,331,000 | +14.1% | 6,116,493 | 0.0% | 0.44% | +38.4% | |
| INTC | INTEL CORPcall | $15,450,000 | -3.3% | 300,000 | 0.0% | 0.42% | +17.0% | |
| TGTX | TG THERAPEUTICS INC | $15,200,000 | -42.9% | 800,000 | 0.0% | 0.41% | -30.9% | |
| VERV | VERVE THERAPEUTICS INC | $14,748,000 | -21.6% | 400,000 | 0.0% | 0.40% | -5.0% | |
| KURA | KURA ONCOLOGY INC | $14,700,000 | -25.3% | 1,050,000 | 0.0% | 0.40% | -9.3% | |
| SQZ | SQZ BIOTECHNOLOGIES CO | $14,344,000 | -38.1% | 1,606,309 | 0.0% | 0.39% | -24.9% | |
| FMTX | FORMA THERAPEUTICS HLDGS INC | $14,220,000 | -38.7% | 1,000,000 | 0.0% | 0.39% | -25.6% | |
| ALBO | ALBIREO PHARMA INC | $13,974,000 | -25.4% | 600,000 | 0.0% | 0.38% | -9.5% | |
| SELB | SELECTA BIOSCIENCES INC | $13,040,000 | -21.6% | 4,000,000 | 0.0% | 0.35% | -4.8% | |
| LPTX | LEAP THERAPEUTICS INC | $12,960,000 | -19.2% | 4,000,000 | 0.0% | 0.35% | -1.9% | |
| TSHA | TAYSHA GENE THERAPIES INC | $12,126,000 | -37.4% | 1,040,882 | 0.0% | 0.33% | -24.2% | |
| OTLY | OATLY GROUP ABsponsored ads | $11,940,000 | -47.4% | 1,500,000 | 0.0% | 0.32% | -36.1% | |
| MARINUS PHARMACEUTICALS INC | $11,880,000 | +4.4% | 1,000,000 | 0.0% | 0.32% | +26.3% | ||
| ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $11,299,000 | -35.7% | 2,255,375 | 0.0% | 0.31% | -21.9% | |
| ALXO | ALX ONCOLOGY HLDGS INC | $10,745,000 | -70.9% | 500,000 | 0.0% | 0.29% | -64.6% | |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $8,776,000 | -37.0% | 1,646,517 | 0.0% | 0.24% | -23.7% | |
| GRPH | GRAPHITE BIO INC | $8,701,000 | -24.2% | 700,000 | 0.0% | 0.24% | -8.2% | |
| DSGN | DESIGN THERAPEUTICS INC | $8,564,000 | +45.7% | 400,000 | 0.0% | 0.23% | +77.1% | |
| ALPN | ALPINE IMMUNE SCIENCES INC | $8,213,000 | +29.8% | 593,030 | 0.0% | 0.22% | +57.0% | |
| NBTX | NANOBIOTIX SAsponsored ads | $8,100,000 | -28.7% | 1,000,000 | 0.0% | 0.22% | -13.4% | |
| ADAG | ADAGENE INCads | $8,068,000 | -43.8% | 1,000,000 | 0.0% | 0.22% | -31.8% | |
| OVID | OVID THERAPEUTICS INC | $8,025,000 | -4.5% | 2,500,000 | 0.0% | 0.22% | +16.0% | |
| SPRO | SPERO THERAPEUTICS INC | $8,005,000 | -13.0% | 500,000 | 0.0% | 0.22% | +5.3% | |
| TIL | INSTIL BIO INC | $7,700,000 | -4.3% | 450,000 | 0.0% | 0.21% | +16.1% | |
| HARP | HARPOON THERAPEUTICS INC | $7,550,000 | -4.4% | 1,000,000 | 0.0% | 0.20% | +15.8% | |
| MRSN | MERSANA THERAPEUTICS INC | $7,464,000 | -34.0% | 1,200,000 | 0.0% | 0.20% | -19.8% | |
| ZYME | ZYMEWORKS INC | $7,376,000 | -43.6% | 450,000 | 0.0% | 0.20% | -31.5% | |
| OMEG | OMEGA ALPHA SPACcl a | $7,328,000 | +0.4% | 750,000 | 0.0% | 0.20% | +22.1% | |
| IMCR | IMMUNOCORE HLDGS PLCads | $6,848,000 | -7.6% | 200,000 | 0.0% | 0.19% | +12.0% | |
| IMUX | IMMUNIC INC | $6,699,000 | +8.1% | 700,000 | 0.0% | 0.18% | +30.9% | |
| YMAB | Y-MABS THERAPEUTICS INC | $6,484,000 | -43.2% | 400,000 | 0.0% | 0.18% | -31.0% | |
| VOR | VOR BIOPHARMA INC | $6,391,000 | -25.9% | 550,000 | 0.0% | 0.17% | -10.4% | |
| DYN | DYNE THERAPEUTICS INC | $6,242,000 | -26.8% | 525,000 | 0.0% | 0.17% | -11.5% | |
| SANA | SANA BIOTECHNOLOGY INC | $6,192,000 | -31.3% | 400,000 | 0.0% | 0.17% | -16.8% | |
| CRIS | CURIS INC | $6,188,000 | -39.2% | 1,300,000 | 0.0% | 0.17% | -26.3% | |
| CARIBOU BIOSCIENCES INC | $6,117,000 | -36.8% | 405,347 | 0.0% | 0.17% | -23.1% | ||
| EVLO | EVELO BIOSCIENCES INC | $6,070,000 | -13.8% | 1,000,000 | 0.0% | 0.16% | +4.4% | |
| STOK | STOKE THERAPEUTICS INC | $5,998,000 | -5.7% | 250,000 | 0.0% | 0.16% | +14.8% | |
| ORIC | ORIC PHARMACEUTICALS INC | $5,880,000 | -29.7% | 400,000 | 0.0% | 0.16% | -14.4% | |
| NEXI | NEXIMMUNE INC | $5,532,000 | -69.6% | 1,200,000 | 0.0% | 0.15% | -63.1% | |
| LYEL | LYELL IMMUNOPHARMA INC | $5,418,000 | -47.7% | 700,000 | 0.0% | 0.15% | -36.6% | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $5,280,000 | -18.9% | 3,000,000 | 0.0% | 0.14% | -2.1% | |
| SLDB | SOLID BIOSCIENCES INC | $5,250,000 | -26.8% | 3,000,000 | 0.0% | 0.14% | -11.2% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $4,964,000 | -40.3% | 1,045,000 | 0.0% | 0.14% | -27.4% | |
| ACIU | AC IMMUNE SA | $4,950,000 | -26.2% | 1,000,000 | 0.0% | 0.13% | -10.7% | |
| DYNS | DYNAMICS SPECIAL PURPOSE COR | $4,930,000 | -0.8% | 500,000 | 0.0% | 0.13% | +20.7% | |
| CYCN | CYCLERION THERAPEUTICS INC | $4,780,000 | -44.0% | 2,779,122 | 0.0% | 0.13% | -31.9% | |
| GDS | GDS HLDGS LTDsponsored ads | $4,716,000 | -16.7% | 100,000 | 0.0% | 0.13% | +0.8% | |
| IQ | IQIYI INCsponsored ads | $4,560,000 | -43.2% | 1,000,000 | 0.0% | 0.12% | -31.1% | |
| CRDF | CARDIFF ONCOLOGY INC | $4,508,000 | -9.7% | 750,000 | 0.0% | 0.12% | +8.9% | |
| BBIO | BRIDGEBIO PHARMA INC | $4,170,000 | -64.4% | 250,000 | 0.0% | 0.11% | -56.9% | |
| CFRX | CONTRAFECT CORP | $3,945,000 | -35.1% | 1,500,000 | 0.0% | 0.11% | -21.3% | |
| PORTAGE FINTECH ACQUISITN CO | $3,781,000 | -0.5% | 380,000 | 0.0% | 0.10% | +21.2% | ||
| APLT | APPLIED THERAPEUTICS INC | $3,580,000 | -46.1% | 400,000 | 0.0% | 0.10% | -34.9% | |
| TCRR | TCR2 THERAPEUTICS INC | $3,495,000 | -45.2% | 750,000 | 0.0% | 0.10% | -33.6% | |
| RXRX | RECURSION PHARMACEUTICALS INcl a | $3,426,000 | -25.6% | 200,000 | 0.0% | 0.09% | -9.7% | |
| YI | 111 INCads | $3,382,000 | -43.3% | 966,349 | 0.0% | 0.09% | -30.8% | |
| IMMP | IMMUTEP LTDsponsored ads | $3,280,000 | -15.2% | 1,000,000 | 0.0% | 0.09% | +2.3% | |
| FUSN | FUSION PHARMACEUTICALS INC | $3,128,000 | -47.3% | 750,000 | 0.0% | 0.08% | -36.1% | |
| WVE | WAVE LIFE SCIENCES LTD | $3,140,000 | -35.9% | 1,000,000 | 0.0% | 0.08% | -22.7% | |
| KDNY | CHINOOK THERAPEUTICS INC | $2,944,000 | +27.8% | 180,500 | 0.0% | 0.08% | +53.8% | |
| ARAV | ARAVIVE INC | $2,872,000 | -41.1% | 1,311,291 | 0.0% | 0.08% | -28.4% | |
| MEIP | MEI PHARMA INC | $2,670,000 | -3.3% | 1,000,000 | 0.0% | 0.07% | +16.1% | |
| OLMA | OLEMA PHARMACEUTICALS INC | $2,438,000 | -66.0% | 260,500 | 0.0% | 0.07% | -59.0% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $2,381,000 | -42.6% | 1,803,858 | 0.0% | 0.06% | -30.1% | |
| MREO | MEREO BIOPHARMA GROUP PLCads | $2,400,000 | -33.9% | 1,500,000 | 0.0% | 0.06% | -19.8% | |
| KNTE | KINNATE BIOPHARMA INC | $2,215,000 | -23.0% | 125,000 | 0.0% | 0.06% | -6.2% | |
| CDAK | CODIAK BIOSCIENCES INC | $2,228,000 | -31.8% | 200,000 | 0.0% | 0.06% | -17.8% | |
| HIPPO HLDGS INC | $1,698,000 | -39.5% | 600,000 | 0.0% | 0.05% | -27.0% | ||
| AMYT | AMRYT PHARMA PLCsponsored ads | $1,625,000 | -10.4% | 150,480 | 0.0% | 0.04% | +7.3% | |
| AXLA | AXCELLA HEALTH INC | $1,489,000 | -29.9% | 712,500 | 0.0% | 0.04% | -16.7% | |
| HOOK | HOOKIPA PHARMA INC | $1,397,000 | -60.4% | 599,616 | 0.0% | 0.04% | -51.9% | |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $1,289,000 | -10.7% | 110,532 | 0.0% | 0.04% | +9.4% | |
| CRVS | CORVUS PHARMACEUTICALS INC | $1,205,000 | -50.2% | 500,000 | 0.0% | 0.03% | -38.9% | |
| KLDO | KALEIDO BIOSCIENCES INC | $1,196,000 | -56.2% | 500,500 | 0.0% | 0.03% | -47.5% | |
| LVTX | LAVA THERAPEUTICS NV | $1,100,000 | -7.1% | 200,000 | 0.0% | 0.03% | +15.4% | |
| DCPH | DECIPHERA PHARMACEUTICALS IN | $977,000 | -71.2% | 100,000 | 0.0% | 0.03% | -64.5% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $851,000 | -27.0% | 321,100 | 0.0% | 0.02% | -11.5% | |
| SGTX | SIGILON THERAPEUTICS INC | $762,000 | -51.1% | 276,000 | 0.0% | 0.02% | -40.0% | |
| YMTX | YUMANITY THERAPEUTICS INC | $643,000 | -71.3% | 217,391 | 0.0% | 0.02% | -66.0% | |
| MTCR | METACRINE INC | $624,000 | -80.3% | 924,898 | 0.0% | 0.02% | -76.1% | |
| SURF | SURFACE ONCOLOGY INC | $478,000 | -36.9% | 100,000 | 0.0% | 0.01% | -23.5% | |
| CDTX | CIDARA THERAPEUTICS INC | $285,000 | -43.3% | 224,675 | 0.0% | 0.01% | -27.3% | |
| ASTRIA THERAPEUTICS INC | $180,000 | -39.0% | 33,333 | 0.0% | 0.01% | -28.6% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-06-07 |
| 13F-HR/A | 2024-05-17 |
| 4 | 2024-05-14 |
| 13F-HR | 2024-05-13 |
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.